Healthy Choice Compounding LLC, Elmsford, NY

Is Healthy Choice Compounding LLC registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Healthy Choice Compounding LLC hold a New York pharmacy license?

State pharmacy license records for New York are not checked: the Office of the Professions’ online verification search requires an access key and a check that the user is a person, and its bulk verification files are released only on request. This index reads only that state’s board actions. The Connecticut Department of Consumer Protection also lists nonresident license PCN.0002208 for HEALTHY CHOICE COMPOUNDING LLC, Elmsford, NY, status ACTIVE (CURRENT), as of Nov 15, 2026.

Has Healthy Choice Compounding LLC had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter close-out (Dec 21, 2023), 1 untitled letter (Jul 15, 2022), 1 state referral letter (Dec 21, 2023) and 1 FMD-145 letter (Dec 21, 2023) for Healthy Choice Compounding LLC. State board actions: no New York State Education Department action under this exact name and city was found in the New York State Education Department’s list of Board of Regents disciplinary actions against pharmacy establishments (actions dated Jan 14, 1994 to May 19, 2026) on Nov 8, 2026. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Healthy Choice Compounding LLC
Location
Elmsford, NY
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
1
Warning letters on FDA’s actions page
0
Latest action on that page
Dec 21, 2023
FDA Data Dashboard inspections
2 inspections: 1 OAI, 1 VAI; 2 published Form 483s
Form 483 text on this page
1 Form 483, 3 observations
State board records
Not checked (license records); board actions matched: 0

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Healthy Choice Compounding LLC, a 503A facility, with 5 dated actions.

Document
Dec 21, 2023State referral letterState Referral Letter Issued 12/21/2023Not linked by FDA
Dec 21, 2023FMD-145 letterFMD-145 Letter Issued 12/21/2023Not linked by FDA
Dec 21, 2023Warning letter close-outWarning Letter Closeout Issued 12/21/2023Not linked by FDA
Jul 15, 2022Untitled letterUntitled Letter Issued 07/15/2022fda.gov
Sep 24, 2020Form 483483 Issued 09/24/2020fda.gov

A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists Healthy Choice Compounding LLC, Elmsford, NY (FEI number 3013118095), matched to this page by exact name, city and state. It lists 2 inspections: 1 OAI, 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.

Inspection endedClassificationProject area and product typeFEIInspection ID
Sep 24, 2020Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs)30131180951129874
Feb 28, 2017Official Action Indicated (OAI)Drug Quality Assurance (Drugs)30131180951006034

Form 483s FDA has published for this site

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 3 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Sep 17, 2020 to Sep 24, 2020: 3 observations

Firm on the cover
Healthy Choice Compounding LLC, 250 Clearbrook Rd, Elmsford, NY 10523-1305
FEI number
3013118095
Establishment type on the cover
Producer of non-sterile drug products
FDA district office on the cover
158-15 Liberty Avenue Jamaica, NY 11433
Matched to this page by
FEI number on the cover; linked from Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

Observation 1

You produced hazardous drugs without providing adequate segregation, cleaning of work surfaces and cleaning of utensils to prevent cross-contamination.

Specifically,

(A) The capsule machine is not cleaned with a deactivating agent after each compounding preparation. On 9/21/2020, I observed the technician compounding DI-EST PROG TEST SR 2.5/50/0.5 MG CAPSULE (Lot # 09182020@38), ESTRADIOL DHEA SR 0.25/5 MG CAPSULE (Lot # 09212020@2), and DHEA MICRO SR <Redacted B4> (CLEAR/VEGGIE) 2.5 MG CAPSULE (Lot # 09212020@15). The capsule machine was vacuumed to remove remnants of <Redacted B4> and only wiped cleaned with <Redacted B4> in between compounding preparations.

(B) Deactivating agent is not used to clean the non-dedicated equipment used in the preparation of non -hazardous and hazardous drug products.

Observation 2

You used a non-pharmaceutical grade component in the formulation of a drug product.

Specifically, <Redacted B4> water was used as an ingredient in non-sterile compounded drug products, such as NALTREXONE 4 MG/ML LIQUID (Lot # 06032020@68) for Rx # <Redacted B6>. Your firm did not conduct microbial and/or chemical analysis to ensure the quality of <Redacted B6> water used in your compounded preparations is pharmaceutical grade.

Observation 3

Your firm released drug product in which the strength differs from, or its purity or quality falls below, that which it purports or is represented to possess.

Specifically, the following lots of compounded drug preparations were found to be out of specification after the lots were dispensed. However, no recall of the dispensed prescriptions was initiated following the receipt of the lab results.

Potency <

Compounded Drug Product

Lot #

Redacted B 4>

DI-EST SR 2.0 MG CAPSULE

09152017@21

Estriol 134%

NALTREXONE 4.5 MG CAPSULE

10222019@31

86.5%

ESTRIOL DHEA 0.5/6.25 MG/GM VAGINAL

10152019@40

Estriol 84.8%

ESTRADIOL (OLIVE OIL) 0.01% (0.1 MG/GM) VAGINAL

11262019@43

43.6%

HYDROXYCHLOROQUINE ZINC 200/10 MG CAPS

04082020@57

Zinc 82.0%

Linked 483s whose text is not shown

State board of pharmacy records

State pharmacy license records for New York are not checked: the Office of the Professions’ online verification search requires an access key and a check that the user is a person, and its bulk verification files are released only on request. This index reads only that state’s board actions. Board actions source.

What this covers: Board of Regents disciplinary actions against pharmacy establishments from the Office of the Professions’ summaries for the pharmacy profession, which start in 1994 (105 of 105 list pages read). These are final Regents actions, mostly consent orders; open complaints and charges not yet decided are not listed. Actions against individual pharmacists are not copied. New York pharmacy licenses and registrations are not checked. Actions in the data are dated Jan 14, 1994 to May 19, 2026.

Nonresident licenses in other states

These boards list a nonresident license whose record names this pharmacy’s own name, city and state.

Connecticut Department of Consumer Protection, file dated Nov 15, 2026 (Connecticut).

LicenseType as the board gives itName on the board recordLocationStatus
PCN.0002208NONRESIDENT PHARMACYHEALTHY CHOICE COMPOUNDING LLCElmsford, NYACTIVE (CURRENT)

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.